Imunon Inc (IMNN)

06:29 AM

Insider Sell: Susan Eylward Sells Shares of Imunon Inc (IMNN) - GuruFocus

06:29 AM

05:44 AM

Imunon general counsel Susan Eylward sells $1,729 in company stock - Investing.com

05:44 AM

05:06 AM

Form 4 Imunon Inc For: 7 July By Investing.com - Investing.com Canada

05:06 AM

05:05 AM

Imunon (IMNN) Executive Chairman receives 4,410-share stock grant as salary - Stock Titan

05:05 AM

05:01 AM

Imunon (IMNN) CFO Joshua Blacher files initial insider Form 3 ownership report - Stock Titan

05:01 AM

04:58 AM

Imunon (IMNN) General Counsel reports stock grant and 920-share sale - Stock Titan

04:58 AM

04:57 AM

Imunon (IMNN) CMO granted stock in lieu of part of salary - Stock Titan

04:57 AM

04:56 AM

Imunon (IMNN) CEO Stacy Lindborg receives stock grant instead of cash salary - Stock Titan

04:56 AM

Jul 06, 2026

Imunon 1Q Loss/Shr 84c >IMNN - Moomoo

Jul 06, 2026

Jul 03, 2026

IMNNImunon Inc Latest SEC Filings - Finviz

Jul 03, 2026

Jul 01, 2026

IMUNON announces executive transition: Josh Blacher appointed interim CFO as Jeffrey Church retires - MSN

Jul 01, 2026

Jun 30, 2026

Imunon (IMNN) Reorganizes Financial Leadership Ahead of CFO Tran - GuruFocus

Jun 30, 2026

Jun 30, 2026

Imunon interim CFO Jeffrey Church to retire, Josh Blacher to succeed - TipRanks

Jun 30, 2026

Jun 30, 2026

ImunonJeffrey Church To Retire As Interim CFO Effective July 1, 2026SEC Filing - TradingView

Jun 30, 2026

Jun 30, 2026

Imunon Names Josh Blacher Interim Chief Financial Officer - TipRanks

Jun 30, 2026

Jun 30, 2026

Imunon CFO Jeffrey Church to Retire; Josh Blacher Named Interim CFO - TradingView

Jun 30, 2026

Jun 30, 2026

Imunon (NASDAQ: IMNN) appoints Josh Blacher as interim CFO - Stock Titan

Jun 30, 2026

Jun 30, 2026

Imunon, Inc. Appoints Josh Blacher as Principal Financial Officer and Principal Accounting Officer, Effective July 1, 2026 - marketscreener.com

Jun 30, 2026

Jun 29, 2026

Insider Sell: Susan Eylward Sells 11,800 Shares of Imunon Inc (I - GuruFocus

Jun 29, 2026

Jun 29, 2026

Form 4 Imunon Inc For: 29 June By Investing.com - Investing.com South Africa

Jun 29, 2026

Jun 29, 2026

Imunon (IMNN) Chief Medical Officer granted 21,896 shares in lieu of 2025 cash bonus - Stock Titan

Jun 29, 2026

Jun 29, 2026

Imunon (IMNN) counsel gets stock bonus, then sells 11,800 shares - Stock Titan

Jun 29, 2026

Jun 29, 2026

Imunon (IMNN) chair takes half of 2025 cash bonus in stock grant - Stock Titan

Jun 29, 2026

Jun 29, 2026

Imunon (IMNN) CEO awarded 67,150 shares instead of cash bonus - Stock Titan

Jun 29, 2026

Jun 29, 2026

Imunon Secures $10 Million Funding Package to Advance Phase 3 Ovarian Cancer Study (IMNN) - MSN

Jun 29, 2026

Jun 29, 2026

Enterprise value to EBITDA forward of Imunon, Inc. – NASDAQ:IMNN - TradingView

Jun 29, 2026

Jun 28, 2026

Price to earnings forward of Imunon, Inc. – DUS:CBO0 - TradingView

Jun 28, 2026

Jun 28, 2026

Price to sales forward of Imunon, Inc. – NASDAQ:IMNN - TradingView

Jun 28, 2026

Jun 28, 2026

Enterprise value to revenue forward of Imunon, Inc. – NASDAQ:IMNN - TradingView

Jun 28, 2026

Jun 28, 2026

Price to book forward of Imunon, Inc. – NASDAQ:IMNN - TradingView

Jun 28, 2026

Jun 27, 2026

Imunon, Inc. Actuals & Estimates (FWB:CBO0) - TradingView

Jun 27, 2026

Jun 27, 2026

Enterprise value to EBITDA forward of Imunon, Inc. – DUS:CBO0 - TradingView

Jun 27, 2026

Jun 27, 2026

Imunon, Inc. Actuals & Estimates (MUN:CBO0) - TradingView

Jun 27, 2026

Jun 27, 2026

Imunon, Inc. Actuals & Estimates (DUS:CBO0) - TradingView

Jun 27, 2026

Jun 26, 2026

Imunon, Inc. (IMNN) Presents at Life Sciences Virtual Investor ForumSlideshow (NASDAQ:IMNN) 2026-06-26 - Seeking Alpha

Jun 26, 2026

Jun 25, 2026

Imunon, Inc. Actuals & Estimates (NASDAQ:IMNN) - TradingView

Jun 25, 2026

Jun 25, 2026

A41CNR Forecast — Price Target — Prediction for 2027 - TradingView

Jun 25, 2026

Jun 25, 2026

IMNN Forecast — Price Target — Prediction for 2027 - TradingView

Jun 25, 2026

Jun 25, 2026

IMNN: IMNN-001 shows unprecedented survival benefit in ovarian cancer, advancing in Phase 3 trials - TradingView

Jun 25, 2026

Jun 23, 2026

Form 4 Imunon Inc For: 23 June By Investing.com - Investing.com South Africa

Jun 23, 2026

Jun 23, 2026

Form 4 Imunon Inc For: 23 June - Investing.com UK

Jun 23, 2026

Jun 23, 2026

Imunon (IMNN) executive chair granted 4,629 shares in lieu of cash pay - Stock Titan

Jun 23, 2026

Jun 23, 2026

Imunon (IMNN) CEO Stacy Lindborg gets 1,803-share stock grant in lieu of salary - Stock Titan

Jun 23, 2026

Jun 23, 2026

Imunon’s ovarian cancer trial continues after committee review By Investing.com - Investing.com India

Jun 23, 2026

Jun 23, 2026

Imunon (IMNN) Phase 3 Trial Receives Green Light from Data Monit - GuruFocus

Jun 23, 2026

Jun 23, 2026

Imunon (IMNN) Phase 3 Trial Receives Green Light from Data Monitoring Committee - GuruFocus

Jun 23, 2026

Jun 23, 2026

Imunon’s ovarian cancer trial continues after committee review - Investing.com

Jun 23, 2026

Jun 23, 2026

IMUNON’s Phase 3 OVATION 3 Trial in Advanced Ovarian Cancer Recommended to Continue by Independent Data Monitoring Committee - Quiver Quantitative

Jun 23, 2026

Jun 23, 2026

IMUNON ovarian cancer trial stays on track after safety review - Stock Titan

Jun 23, 2026

Jun 22, 2026

IMUNON to Present at the Life Sciences Investor Forum on June 25th - GlobeNewswire

Jun 22, 2026